ARMP
Price
$2.17
Change
+$0.23 (+11.86%)
Updated
Jul 3 closing price
Capitalization
78.54M
39 days until earnings call
BOLT
Price
$5.92
Change
+$0.01 (+0.17%)
Updated
Jul 3 closing price
Capitalization
11.35M
33 days until earnings call
Interact to see
Advertisement

ARMP vs BOLT

Header iconARMP vs BOLT Comparison
Open Charts ARMP vs BOLTBanner chart's image
Armata Pharmaceuticals
Price$2.17
Change+$0.23 (+11.86%)
Volume$43.77K
Capitalization78.54M
Bolt Biotherapeutics
Price$5.92
Change+$0.01 (+0.17%)
Volume$928
Capitalization11.35M
ARMP vs BOLT Comparison Chart in %
Loading...
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARMP vs. BOLT commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a StrongBuy and BOLT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ARMP: $2.17 vs. BOLT: $5.92)
Brand notoriety: ARMP and BOLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 13% vs. BOLT: 3%
Market capitalization -- ARMP: $78.54M vs. BOLT: $11.35M
ARMP [@Biotechnology] is valued at $78.54M. BOLT’s [@Biotechnology] market capitalization is $11.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whileBOLT’s FA Score has 1 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • BOLT’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARMP and BOLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARMP’s TA Score shows that 3 TA indicator(s) are bullish while BOLT’s TA Score has 5 bullish TA indicator(s).

  • ARMP’s TA Score: 3 bullish, 3 bearish.
  • BOLT’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, BOLT is a better buy in the short-term than ARMP.

Price Growth

ARMP (@Biotechnology) experienced а +13.61% price change this week, while BOLT (@Biotechnology) price change was +2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ARMP is expected to report earnings on Aug 13, 2025.

BOLT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARMP($78.5M) has a higher market cap than BOLT($11.3M). ARMP YTD gains are higher at: 17.297 vs. BOLT (-44.683). ARMP has higher annual earnings (EBITDA): 13.5M vs. BOLT (-61.54M). BOLT has more cash in the bank: 38.8M vs. ARMP (11.7M). BOLT has less debt than ARMP: BOLT (24.7M) vs ARMP (135M). BOLT has higher revenues than ARMP: BOLT (3.64M) vs ARMP (0).
ARMPBOLTARMP / BOLT
Capitalization78.5M11.3M695%
EBITDA13.5M-61.54M-22%
Gain YTD17.297-44.683-39%
P/E RatioN/AN/A-
Revenue03.64M-
Total Cash11.7M38.8M30%
Total Debt135M24.7M547%
FUNDAMENTALS RATINGS
ARMP: Fundamental Ratings
ARMP
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARMPBOLT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSCR8.64N/A
N/A
Federal Screw Works
HNSBF3.00N/A
N/A
Hansa Medical AB
TROLB29.91N/A
N/A
Tootsie Roll Industries Inc
FMCCP20.00N/A
N/A
Freddie Mac
SKHHY17.73-0.04
-0.21%
Sonic Healthcare Ltd.

BOLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLT has been loosely correlated with XENE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLT jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
-1.33%
XENE - BOLT
39%
Loosely correlated
-0.33%
ATXS - BOLT
38%
Loosely correlated
+1.40%
ELVN - BOLT
35%
Loosely correlated
+0.44%
BHVN - BOLT
35%
Loosely correlated
-0.88%
RLYB - BOLT
34%
Loosely correlated
+3.04%
More